The sides agreed Sept. 19 to a revised drug policy that would drastically change the governance of performance-enhancing drugs. The revision included the final details of HGH testing that had left the sides at odds since it was originally agreed upon since August 2011, when it became part of the current collective bargaining agreement.
Here are the details of the memo circulated by Winston on Friday:
Breer added a few more details:
-- Bill Bradley, contributing editor